SPDR S&P Biotech ETF $XBI Shares Acquired by Clearbridge Investments LLC

Clearbridge Investments LLC raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 395,991 shares of the exchange traded fund’s stock after acquiring an additional 35,483 shares during the quarter. Clearbridge Investments LLC owned approximately 0.59% of SPDR S&P Biotech ETF worth $48,283,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the business. JPMorgan Chase & Co. boosted its position in shares of SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after purchasing an additional 2,900,633 shares during the period. Bessemer Group Inc. boosted its position in shares of SPDR S&P Biotech ETF by 13.5% in the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after purchasing an additional 220,244 shares during the period. Ameriprise Financial Inc. boosted its position in shares of SPDR S&P Biotech ETF by 40.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock valued at $122,906,000 after purchasing an additional 353,351 shares during the period. Greenhouse Funds LLLP boosted its position in shares of SPDR S&P Biotech ETF by 16.6% in the 3rd quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock valued at $67,733,000 after purchasing an additional 96,308 shares during the period. Finally, Assetmark Inc. boosted its position in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after purchasing an additional 635,782 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.2%

Shares of NYSEARCA XBI opened at $128.43 on Tuesday. The stock has a market cap of $8.19 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 52-week low of $80.90 and a 52-week high of $139.19. The business has a 50-day moving average price of $131.99 and a 200 day moving average price of $126.74.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.